|
Viatris holds exclusive rights to commercialise phentolamine ophthalmic solution 0.75% across the US.
|
 |
|
The capital will fund clinical proof-of-concept testing for Estuary's lead gene therapy candidates, EST-101 and EST-201.
|
|
|
Though schools already store autoinjectors like EpiPen, a nasal spray would offer another easy-to-use option.
|
|
|
The duo of funds will support companies across the life sciences landscape – including those in the biopharma, healthcare technology and medtech disciplines.
|
|
|
This deal with insitro sees AstraZeneca double down on its intention to enter the growing MASH market.
|
|
